ALISON WOKULICH: Open Payments
NPI 1376200238 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,288 in 134 payments from 17 companies in 2025. Trend: 2023 $1,766 · 2024 $1,720 · 2025 $2,288
Food & beverage: $2,288
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 37 | $535 |
| Alkermes, Inc. | 16 | $379 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $192 |
| Otsuka America Pharmaceutical, Inc. | 15 | $172 |
| ABBVIE INC. | 13 | $169 |
| E.R. Squibb & Sons, L.L.C. | 13 | $166 |
| Axsome Therapeutics, Inc. | 9 | $165 |
| Janssen Pharmaceuticals, Inc | 6 | $132 |
| Collegium Pharmaceutical, Inc. | 5 | $105 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $69 |
Products named: ARISTADA, UZEDY, AUSTEDO XR, CAPLYTA, VRAYLAR, COBENFY, Auvelity, REXULTI.
Industry payments across PA — which companies pay providers there.
